Royal Fund Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.15M | Buy |
71,225
+2,416
| +4% | +$283K | 0.76% | 37 |
|
|
2026
Q1 | $8.28M | Sell |
68,809
-391
| -0.6% | -$45.1K | 0.79% | 36 |
|
|
2025
Q4 | $7.29M | Buy |
69,200
+4,380
| +7% | +$411K | 0.66% | 50 |
|
|
2025
Q3 | $5.44M | Sell |
64,820
-3,853
| -6% | -$317K | 0.65% | 50 |
|
|
2025
Q2 | $5.44M | Buy |
68,673
+7,805
| +13% | +$620K | 0.54% | 57 |
|
|
2025
Q1 | $5.5M | Buy |
60,868
+5,474
| +10% | +$511K | 0.61% | 51 |
|
|
2024
Q4 | $5.55M | Buy |
55,394
+1,161
| +2% | +$120K | 0.52% | 59 |
|
|
2024
Q3 | $6.2M | Buy |
54,233
+4,740
| +10% | +$563K | 0.37% | 66 |
|
|
2024
Q2 | $6.18M | Sell |
49,493
-4,213
| -8% | -$543K | 0.5% | 37 |
|
|
2024
Q1 | $7.09M | Sell |
53,706
-4,859
| -8% | -$599K | 0.7% | 31 |
|
|
2023
Q4 | $6.39M | Buy |
58,565
+880
| +2% | +$91.3K | 0.71% | 32 |
|
|
2023
Q3 | $5.94M | Sell |
57,685
-32
| -0.1% | -$3.45K | 0.8% | 32 |
|
|
2023
Q2 | $6.66M | Sell |
57,717
-641
| -1% | -$72.8K | 0.83% | 30 |
|
|
2023
Q1 | $6.21M | Sell |
58,358
-2,360
| -4% | -$255K | 0.89% | 31 |
|
|
2022
Q4 | $6.74M | Sell |
60,718
-99
| -0.2% | -$10.1K | 1.07% | 25 |
|
|
2022
Q3 | $5.24M | Sell |
60,817
-1,453
| -2% | -$130K | 0.95% | 31 |
|
|
2022
Q2 | $5.68M | Buy |
62,270
+58
| +0.1% | +$5.14K | 0.94% | 33 |
|
|
2022
Q1 | $5.1M | Sell |
62,212
-1,768
| -3% | -$139K | 0.74% | 47 |
|
|
2021
Q4 | $4.9M | Sell |
63,980
-458
| -0.7% | -$36.5K | 0.7% | 52 |
|
|
2021
Q3 | $4.84M | Buy |
64,438
+1,708
| +3% | +$130K | 0.71% | 49 |
|
|
2021
Q2 | $4.88M | Buy |
62,730
+8,387
| +15% | +$624K | 0.81% | 47 |
|
|
2021
Q1 | $4M | Buy |
54,343
+15,090
| +38% | +$1.11M | 0.73% | 56 |
|
|
2020
Q4 | $3.06M | Buy |
39,253
+2,555
| +7% | +$195K | 0.65% | 62 |
|
|
2020
Q3 | $2.9M | Buy |
36,698
+4,600
| +14% | +$360K | 0.74% | 61 |
|
|
2020
Q2 | $2.37M | Buy |
32,098
+5,279
| +20% | +$397K | 0.84% | 56 |
|
|
2020
Q1 | $1.97M | Buy |
26,819
+21,675
| +421% | +$1.7M | 0.8% | 47 |
|
|
2019
Q4 | $446K | Sell |
5,144
-655
| -11% | -$53.8K | 0.11% | 91 |
|
|
2019
Q3 | $465K | Sell |
5,799
-37
| -0.6% | -$2.96K | 0.13% | 82 |
|
|
2019
Q2 | $466K | Sell |
5,836
-448
| -7% | -$34.3K | 0.14% | 80 |
|
|
2019
Q1 | $498K | Buy |
6,284
+3,512
| +127% | +$263K | 0.16% | 72 |
|
|
2018
Q4 | $202K | Buy |
2,772
+24
| +0.9% | +$1.69K | 0.08% | 107 |
|
|
2018
Q3 | $186K | Sell |
2,748
-279
| -9% | -$17.8K | 0.06% | 120 |
|
|
2018
Q2 | $175K | Sell |
3,027
-1,346
| -31% | -$75.9K | 0.06% | 118 |
|
|
2018
Q1 | $227K | Sell |
4,373
-99
| -2% | -$5.35K | 0.08% | 114 |
|
|
2017
Q4 | $240K | Sell |
4,472
-122,454
| -96% | -$6.79M | 0.09% | 102 |
|
|
2017
Q3 | $7.75M | Sell |
126,926
-1,663
| -1% | -$101K | 3.09% | 6 |
|
|
2017
Q2 | $7.86M | Buy |
128,589
+16,262
| +14% | +$990K | 3.34% | 7 |
|
|
2017
Q1 | $6.81M | Buy |
112,327
+8,236
| +8% | +$500K | 3.29% | 8 |
|
|
2016
Q4 | $5.85M | Buy |
+104,091
| New | +$6.09M | 3.24% | 12 |
|
Other funds holding MRK
LMFP
ATO
QP
Royal Fund Management's MRK Position: Q2 2026 in Review
Royal Fund Management increased its Merck (MRK) stake by 3.5% in Q2 2026, buying an estimated $283K and bringing the position to 71,225 shares worth $9.15M. The position accounts for 0.76% of the portfolio, ranked #37.
Royal Fund Management first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Royal Fund Management held 71,225 shares of Merck worth $9.15M as of Q2 2026.
- Royal Fund Management bought 2,416 Merck shares in Q2 2026, an estimated $283K.
- Merck made up 0.76% of Royal Fund Management's portfolio in Q2 2026, its #37 holding.
- Royal Fund Management first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.